Cargando…

Real-time Feedback to Improve HIV Treatment Adherence in Pregnant and Postpartum Women in Uganda: A Randomized Controlled Trial

We assessed an intervention aimed at improving adherence to antiretroviral therapy (ART) among pregnant and postpartum women living with HIV (PPWLH). We randomized 133 pregnant women initiating ART in Uganda to receive text reminders generated by real time-enabled electronic monitors and data-inform...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabin, Lora L., Simmons, Elizabeth, Halim, Nafisa, Hamer, Davidson H., Gifford, Allen L., West, Rebecca L., Larson, Anna, Bonawitz, Rachael, Aroda, Philip, Banigbe, Bolanle, Holderman, Alayna J., Murray, Lisa, DeSilva, Mary B., Gasuza, Julia, Mukasa, Barbara, Messersmith, Lisa J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640413/
https://www.ncbi.nlm.nih.gov/pubmed/35704124
http://dx.doi.org/10.1007/s10461-022-03712-7
Descripción
Sumario:We assessed an intervention aimed at improving adherence to antiretroviral therapy (ART) among pregnant and postpartum women living with HIV (PPWLH). We randomized 133 pregnant women initiating ART in Uganda to receive text reminders generated by real time-enabled electronic monitors and data-informed counseling through 3 months postpartum (PPM3) or standard care. Intention-to-treat analyses found low adherence levels and no intervention impact. Proportions achieving ≥95% adherence in PPM3 were 16.4% vs. 9.1% (t = -1.14, p = 0.26) in intervention vs. comparison groups, respectively; 30.9% vs. 29.1% achieved ≥80% adherence. Additional analyses found significant adherence declines after delivery, and no effect on disease progression (CD4-cell count, viral load), though treatment interruptions were significantly fewer in intervention participants. Per-protocol analyses encompassing participants who used adherence monitors as designed experienced better outcomes, suggesting potential benefit for some PPWLH. The study was registered on ClinicalTrials.Gov (NCT02396394). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10461-022-03712-7.